Category: Gynecology > HPV / cervical screening
Took PCERV for 6 months and still HPV-positive — do ads that “clear the virus” work?
PCERV is a dietary supplement, not an HPV drug. Marketplace “clear in 6 months” is ad copy. CDC teaching: about 9 in 10 HPV infections go away within 2 years — not a jar result. Pap/HPV DNA follow-up and ASCCP pathways are the clinical frame — not a 6-month capsule course.
Red flags: when to see a gynecologist — not wait out 6 months
Bleeding after sex, postmenopausal bleeding, unexplained pelvic pain, foul discharge, fever, CIN2/CIN3 or cancer, a missed colposcopy visit, or pregnancy plus an abnormal screen — see a clinician now. Do not wait for a 6-month jar.
Management frame:
ASCCP management guidelines.
Virus overview:
CDC — HPV.
- Bleeding after sex — not a 6-month ad cutoff
- Postmenopausal bleeding — cervix/uterus need assessment
- Unexplained pelvic pain, foul discharge, or fever
- CIN2 / CIN3 or cancer — a different layer from a supplement; see
HPV16/18 CIN1 to CIN3 and LEEP - Missed colposcopy, or pregnancy plus an abnormal result — do not wait on a jar
How does a 6-month ad differ from CDC’s 1–2 years and ASCCP?
A 6-month clip cutoff is a sales beat, not an HPV assessment frame.
CDC
teaches that many HPV infections clear within 1–2 years — general teaching, not proof that Lediiso PCERV cleared the virus.
WHO — HPV and cancer
stresses HPV vaccine and screening.
Abnormal-result pathways use
ASCCP,
not a capsule course.
Ad layer: “clear the virus in 6 months”
Marketplace copy often says HPV clears in 6 months and cites Italian oral research.
This page does not treat “clears HPV directly,” “first in Thailand,” or “speed clearance within 6 months” as facts about this jar.
The Italian four-molecule papers are not an RCT of this SKU — read
Italian EGCG combo ≠ this jar.
Biology layer: many clear in 1–2 years
Clearance in 1–2 years is an immune-system window in CDC teaching, not a pass to skip repeat testing.
A positive result at month 6 is still inside that 1–2 year frame and does not prove a supplement failed as a drug — because it is not a drug.
Clinic layer: Pap / HPV DNA and ASCCP
Screening follows USPSTF: ages 21–29 cytology every 3 years; ages 30–65 every 3 years or high-risk HPV every 5 years — see
USPSTF cervical screening
and
NCI cervical screening.
If results point to colposcopy or LEEP, keep the appointment. A supplement does not close that layer — read
Do not skip screening.
CDC teaching: about 9 in 10 HPV infections go away within 2 years.
USPSTF: ages 21–29 cytology every 3 years; ages 30–65 cytology every 3 years, or high-risk HPV every 5 years, or co-testing every 5 years.
A 6-month ad course is shorter than both frames.
Teaching bars, not Thai patient data, and not a prediction of when a jar clears virus.
What PCERV is — and is not
Lediiso PCERV is a dietary supplement, not an HPV drug and not a cervical-cancer treatment.
Marketplace listings often name 8 ingredients: EGCG (green tea), vitamin B12, folic acid, white wood-ear mushroom marketed as a hyaluronic-acid source, pomegranate extract, graviola/soursop, Lactobacillus rhamnosus, and Lactobacillus crispatus.
Clip lists are sales copy. Read the label in your hand; this page does not invent a dose.
Dose: follow the label, not the clip
If the label in your hand sets a capsule count or duration that differs from a video, follow the label.
If a registration number appears on the jar, read it there — this page does not invent a Thai FDA (อย.) number.
Supplement registration does not turn the product into an HPV medicine.
Read the probiotic-facts layer at
HPV probiotics and supplements.
Get a severity-level analysis from our Advisory team
Get a severity-level analysis and personalized guidance from our Advisory team
Layer comparison: HPV vaccine / screening / colposcopy–LEEP / 1–2 year clearance / PCERV
A supplement is not the same cutoff as HPV vaccine or an ASCCP pathway — 1–2 year clearance is CDC teaching, not a jar result.
| Tool | Layer | Assessment window | What it can do | Limits |
|---|---|---|---|---|
| HPV vaccine | Prevents covered types when indicated | Per the vaccine schedule — not a 6-month jar course | Lowers cervical-cancer risk in the WHO/CDC frame | Does not treat existing infection; not PCERV |
| Pap / HPV DNA | Screening per USPSTF / NCI | USPSTF: 21–29 every 3 years; 30–65 every 3 or 5 years — not a 6-month ad cutoff | Finds abnormal cells and persistent virus | A supplement does not close the test cycle |
| Colposcopy / LEEP per ASCCP | Diagnosis and excision when criteria are met | Per the clinician visit — do not delay for a jar | Manages CIN on guideline | Different layer from a supplement; CIN2/3 does not wait on an ad |
| Watchful waiting / natural clearance 1–2 years (CDC) | Immune clearance in many people | CDC: ~2 years (9 in 10) — not a 6-month clip | Explains why month-6 positivity can still sit in the biology window | Not a pass to skip tests; not a PCERV result |
| PCERV (Lediiso) | Dietary supplement | Marketplace copy often says ~6 months — not an ASCCP cutoff | Read the label in your hand; do not invent a dose from a clip | Not an HPV drug; no public RCT of this SKU clearing virus in 6 months |
Still HPV-positive after about 6 months — what does that mean?
A positive result at 6 months does not prove HPV vaccine or screening failed, and it does not turn PCERV into a drug.
In the CDC frame, many people are still inside a 1–2 year window.
Return to the Pap/HPV DNA visit and the ASCCP plan — do not add a jar course in place of testing.
If the result is new, open
newly diagnosed HPV — exam steps
and
HPV-positive guide.
Frequently asked questions
Do ads that “clear HPV in 6 months” work as a clinical cutoff?
“Clear in 6 months” is sales copy, not a clinical cutoff. CDC teaching: about 9 in 10 HPV infections go away within 2 years. Follow-up is Pap/HPV DNA and ASCCP pathways — not a capsule course.
If I took PCERV for 6 months and I am still HPV-positive, did the jar fail?
A positive result at 6 months does not prove a supplement failed as a drug, because PCERV is not an HPV drug and is not the same cutoff as CDC’s 1–2 year clearance window or an ASCCP pathway.
Is PCERV an HPV drug or a cervical-cancer treatment?
No. Lediiso PCERV is a dietary supplement, not an HPV drug and not a cervical-cancer treatment. A 6-month ad does not turn the jar into a medicine.
Does a Thai FDA (อย.) number on the jar mean it is an HPV medicine?
No. Read the label in your hand. This page does not invent a Thai FDA number. Supplement registration is not drug approval for HPV.
If CDC says many infections clear in 1–2 years, can I skip further tests?
No. Natural clearance is general CDC teaching, not a pass to skip Pap or HPV DNA testing, and not proof that this jar cleared the virus.
If I take a supplement, can I skip Pap or HPV DNA tests?
No. USPSTF/NCI screening and ASCCP management sit on a different layer from a supplement. See the do-not-skip page in this cluster.
If I am pregnant with an abnormal screen, can this jar replace seeing a clinician?
No. Pregnancy plus an abnormal screen is a red flag. See a gynecologist. Do not wait out a 6-month jar course.
Are the Italian EGCG / folate / B12 / hyaluronic acid ads an RCT of this jar?
No. PMID 36983172 and 40508059 studied a four-molecule Italian formula. That is not an RCT of the Lediiso jar, whose ads also list pomegranate, graviola, and two lactobacilli.
Scientific mechanism (author synthesis)
Most HPV is cleared by immunity over years, not over a 6-month capsule course, and persistence must be separated from CIN managed on ASCCP.
Asst. Prof. Dr. Norawit Raatpiboon
synthesizes that
CDC
teaching on 1–2 year clearance can explain month-6 positivity without a jar.
WHO
places HPV vaccine and screening on the cancer-prevention layer.
The Italian pilot of EGCG 200 mg + folate 400 µg + B12 1 mg + hyaluronic acid 50 mg for 12 weeks, n=40
(PMID 36983172)
and the single-arm 6-month n=106 paper
(PMID 40508059)
are not RCTs of this Thai jar.
Academic citations (E-E-A-T)
- CDC — HPV about (about 9 in 10 go away within 2 years — CDC teaching, not a PCERV result)
- WHO — Human papillomavirus and cancer
- ASCCP — Management guidelines
- ACOG — Cervical cancer screening FAQ
- USPSTF — Cervical cancer screening
- NCI — Cervical screening
- Aragona et al. 2023 — oral EGCG + folate + B12 + HA, 12 weeks, n=40 (PMID 36983172) — not PCERV
- 2025 Italian oral four-molecule single-arm, 6 months, n=106 (PMID 40508059) · PMC12155352 — not this Thai SKU
Medical disclaimer
This article and its diagrams are general information from Well Wellness Thailand / dr9ohm.com — not a diagnosis, a prescription, or a results guarantee.
PCERV is a dietary supplement, not an HPV drug and not a cervical-cancer treatment.
It does not replace HPV vaccine, Pap, HPV DNA testing, colposcopy, or LEEP.
Follow the dose on the label in your hand. This page does not invent a Thai FDA number.